High Outlier
Strength
4 mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
54092051902
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
GUANFACINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022037On Market Since
9/2/2009
Pharmacological Classes
Adrenergic alpha2-Agonists
Central alpha-2 Adrenergic Agonist
Related Drugs
Same classification